Carprofen
Carprofen molecule | |
| Clinical data | |
|---|---|
| Trade names | Rimadyl |
| AHFS/Drugs.com | FDA Professional Drug Information |
| License data | |
| Routes of administration | By mouth, injection |
| ATCvet code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | High (99%) |
| Elimination half-life | Approximately 8 h (range 4.5–9.8 h) in dogs |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.053.357 |
| Chemical and physical data | |
| Formula | C15H12ClNO2 |
| Molar mass | 273.72 g·mol−1 |
| 3D model (JSmol) | |
| Chirality | Racemic mixture |
| |
| |
| (verify) | |
Carprofen is a nonsteroidal anti-inflammatory drug (NSAID) of the carbazole and propionic acid class that was previously for use in humans and animals but is now only available to veterinarians for prescribing as a supportive treatment for various conditions in animals. Carprofen reduces inflammation by inhibition of COX-1 and COX-2; its specificity for COX-2 varies from species to species. Marketed under many brand names worldwide, carprofen is used as a treatment for inflammation and pain, including joint pain and postoperative pain.